| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2018 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 300 | $115.55 | $34,665.00 | -0.7% | |
| Jun 25, 2018 | FONR Fonar Corp | Damadian Raymond V | Treasurer | Sell | 1,320 | $27.47 | $36,258.40 | -0.5% | |
| Jun 22, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $4.45 | $44,500.00 | +0.3% | |
| Jun 22, 2018 | NEO Neogenomics Inc | Jones Steven C | Executive Vice President | Sell | 89,688 | $14.04 | $1,259,219.52 | -3.5% | |
| Jun 21, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 30,000 | $4.54 | $136,200.00 | +0.3% | |
| Jun 21, 2018 | FONR Fonar Corp | Damadian Raymond V | Treasurer | Sell | 1,200 | $27.43 | $32,913.00 | -0.5% | |
| Jun 19, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 20,000 | $4.32 | $86,300.00 | +0.3% | |
| Jun 19, 2018 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 10,000 | $14.17 | $141,700.00 | -3.3% | |
| Jun 19, 2018 | VCYT Veracyte, Inc. | Hall Christopher M | President And COO | Sell | 20,000 | $9.02 | $180,464.42 | -23.6% | |
| Jun 19, 2018 | NEO Neogenomics Inc | Jones Steven C | Executive Vice President | Sell | 160,312 | $13.32 | $2,134,566.76 | -2.9% | |
| Jun 18, 2018 | MYGN Myriad Genetics Inc | Marsh Richard M | E.v.p., General Counsel | Sell | 33,000 | $40.00 | $1,320,000.00 | -21.0% | |
| Jun 18, 2018 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 60,000 | $40.12 | $2,407,200.00 | -17.8% | |
| Jun 18, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 14,299 | $4.34 | $62,013.39 | +0.1% | |
| Jun 15, 2018 | IQV Iqvia Holdings Inc. | Bousbib Ari64 | See Remarks | Sell | 92,160 | $103.20 | $9,510,912.00 | -10.5% | |
| Jun 15, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $4.42 | $44,200.00 | +0.3% | |
| Jun 15, 2018 | IQV Iqvia Holdings Inc. | Tpg Group Holdings (sbs) Advisors, Inc.86 | Director | Sell | 6,716,253 | $103.00 | $691,774,059.00 | -29.4% | |
| Jun 15, 2018 | IQV Iqvia Holdings Inc. | Connaughton John | Director | Sell | 1,441,236 | $103.00 | $148,447,308.00 | -27.4% | |
| Jun 15, 2018 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 45,000 | $214.80 | $9,665,817.89 | -5.2% | |
| Jun 15, 2018 | IQV Iqvia Holdings Inc. | Cpp Investment Board Private Holdings, Inc. | 10% Owner | Sell | 9,291,036 | $103.00 | $956,976,708.00 | -41.1% | |
| Jun 14, 2018 | MEDP Medpace Holdings, Inc. | Medpace Limited Partnership | 10% Owner | Sell | 3,000,000 | $41.80 | $125,400,000.00 | -22.4% | |
| Jun 13, 2018 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 50,000 | $217.71 | $10,885,306.80 | -8.3% | |
| Jun 13, 2018 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 350 | $303.42 | $106,197.14 | -14.0% | |
| Jun 13, 2018 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 10,000 | $13.61 | $136,100.00 | -3.2% | |
| Jun 12, 2018 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 12,000 | $8.00 | $96,049.20 | -18.6% | |
| Jun 12, 2018 | XWEL Xwell, Inc. | Jankowski Edward | CEO | Buy | 100,000 | $0.45 | $45,080.00 | +169.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.